The ACME Laboratories Statistics

Total Valuation

DSE:ACMELAB has a market cap or net worth of BDT 14.60 billion. The enterprise value is 37.10 billion.

Market Cap	14.60B
Enterprise Value	37.10B

Important Dates

The next estimated earnings date is Wednesday, October 22, 2025.

Earnings Date	Oct 22, 2025
Ex-Dividend Date	Nov 21, 2024

Share Statistics

DSE:ACMELAB has 211.60 million shares outstanding.

Current Share Class	211.60M
Shares Outstanding	211.60M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	35.92%
Owned by Institutions (%)	3.98%
Float	135.59M

Valuation Ratios

The trailing PE ratio is 6.08.

PE Ratio	6.08
Forward PE	n/a
PS Ratio	0.42
PB Ratio	0.56
P/TBV Ratio	0.56
P/FCF Ratio	n/a
P/OCF Ratio	6.13
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.70, with an EV/FCF ratio of -26.40.

EV / Earnings	15.44
EV / Sales	1.07
EV / EBITDA	4.70
EV / EBIT	5.96
EV / FCF	-26.40

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.96.

Current Ratio	1.08
Quick Ratio	0.26
Debt / Equity	0.96
Debt / EBITDA	3.18
Debt / FCF	-17.89
Interest Coverage	2.17

Financial Efficiency

Return on equity (ROE) is 9.52% and return on invested capital (ROIC) is 7.89%.

Return on Equity (ROE)	9.52%
Return on Assets (ROA)	6.89%
Return on Invested Capital (ROIC)	7.89%
Return on Capital Employed (ROCE)	18.02%
Revenue Per Employee	3.74M
Profits Per Employee	258,386
Employee Count	9,301
Asset Turnover	0.62
Inventory Turnover	1.66

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.41% in the last 52 weeks. The beta is 0.10, so DSE:ACMELAB's price volatility has been lower than the market average.

Beta (5Y)	0.10
52-Week Price Change	+2.41%
50-Day Moving Average	72.33
200-Day Moving Average	76.76
Relative Strength Index (RSI)	38.03
Average Volume (20 Days)	66,787

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:ACMELAB had revenue of BDT 34.75 billion and earned 2.40 billion in profits. Earnings per share was 11.36.

Revenue	34.75B
Gross Profit	14.58B
Operating Income	6.22B
Pretax Income	3.42B
Net Income	2.40B
EBITDA	7.86B
EBIT	6.22B
Earnings Per Share (EPS)	11.36

Full Income Statement

Balance Sheet

The company has 2.64 billion in cash and 25.14 billion in debt, giving a net cash position of -22.50 billion or -106.35 per share.

Cash & Cash Equivalents	2.64B
Total Debt	25.14B
Net Cash	-22.50B
Net Cash Per Share	-106.35
Equity (Book Value)	26.07B
Book Value Per Share	123.18
Working Capital	1.89B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.38 billion and capital expenditures -3.79 billion, giving a free cash flow of -1.41 billion.

Operating Cash Flow	2.38B
Capital Expenditures	-3.79B
Free Cash Flow	-1.41B
FCF Per Share	-6.64

Full Cash Flow Statement

Margins

Gross margin is 41.96%, with operating and profit margins of 17.90% and 6.92%.

Gross Margin	41.96%
Operating Margin	17.90%
Pretax Margin	9.85%
Profit Margin	6.92%
EBITDA Margin	22.64%
EBIT Margin	17.90%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 5.07%.

Dividend Per Share	3.50
Dividend Yield	5.07%
Dividend Growth (YoY)	6.06%
Years of Dividend Growth	3
Payout Ratio	30.82%
Buyback Yield	n/a
Shareholder Yield	5.14%
Earnings Yield	16.46%
FCF Yield	-9.63%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DSE:ACMELAB has an Altman Z-Score of 1.61. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.61
Piotroski F-Score	n/a